Comparative efficacy of antitumor necrosis factor agents and tacrolimus in naïve steroid-refractory ulcerative colitis patients.

MLA

Kitayama, Moto, et al. “Comparative Efficacy of Antitumor Necrosis Factor Agents and Tacrolimus in Naïve Steroid-Refractory Ulcerative Colitis Patients.” Scientific Reports, vol. 10, no. 1, July 2020, p. 12546. EBSCOhost, https://doi.org/10.1038/s41598-020-68828-z.

APA

Kitayama, M., Akazawa, Y., Yoshikawa, D., Higashi, S., Morisaki, T., Oda, H., Ikeda, M., Nakashima, Y., Tabuchi, M., Hashiguchi, K., Matsushima, K., Yamaguchi, N., Kondo, H., Nakao, K., & Takeshima, F. (2020). Comparative efficacy of antitumor necrosis factor agents and tacrolimus in naïve steroid-refractory ulcerative colitis patients. Scientific Reports, 10(1), 12546. https://doi.org/10.1038/s41598-020-68828-z

Chicago

Kitayama, Moto, Yuko Akazawa, Daisuke Yoshikawa, Shuntaro Higashi, Tomohito Morisaki, Hidetoshi Oda, Maho Ikeda, et al. 2020. “Comparative Efficacy of Antitumor Necrosis Factor Agents and Tacrolimus in Naïve Steroid-Refractory Ulcerative Colitis Patients.” Scientific Reports 10 (1): 12546. doi:10.1038/s41598-020-68828-z.